To print this article, all you need is to be registered or login on Mondaq.com.
On August 24, 2022, Singapore’s Ministry of Health announced a relaxation of the country’s
COVID-related entry restrictions for international travelers.
Specifically, as of August 29, travelers who are not fully
vaccinated are no longer required to complete a seven-day home
isolation period after arrival or complete post-arrival PCR
testing. Singapore’s announcement is part of a recent rollback
of COVID-19 entry requirements by various countries in East Asia,
including Japan and South Korea.
Singapore’s “Vaccinated Travel Framework”
In April 2022, Singapore launched a “Vaccinated Travel
Framework” (VTF) to facilitate the safe resumption of
international travel to and from the country. Under the VTF,
fully-vaccinated travelers have been allowed to enter Singapore
without having to apply for entry approval, take COVID-19 tests, or
undergo a home isolation period after arrival.
International travelers who are not fully vaccinated were
allowed to enter Singapore, but were required to:
- Complete pre-arrival COVID testing within two days of departure
- Undergo a seven-day home isolation period known as a Stay-Home
Notice (SHN); and
- Obtain a negative PCR test upon day 7 of the SHN.
Short-term visitors were also required to secure COVID travel
insurance for the duration of their trip.
In addition, non-fully vaccinated Long-Term Pass Holders (LTPHs)
and short-term visitors aged 13 and above were required to apply
for prior approval in order to enter Singapore.
Updates to the Vaccinated Travel Framework
Under the August 24 announcement, non-fully vaccinated travelers
are no longer required to complete the seven-day SHN or obtain a
negative PCR test upon completion of the SHN. Entry approval
requirements for LTPHs and short-term visitors have also been
Pre-arrival testing is still required, and short-term visitors
must still obtain COVID travel insurance.
To be considered fully vaccinated by the Singaporean
government, travelers must have taken at least one dose of
Janssen/Johnson & Johnson, or at least 2 doses of AstraZeneca,
Covaxin, Moderna, Covishield, Novavax, Pfizer-BioNTech, Sinovac, or
Sinopharm. Mixtures and boosters of these vaccines, and recovery
from COVID-19 with vaccination, are also acceptable.
Visit us at
Mayer Brown is a global legal services provider
comprising legal practices that are separate entities (the
“Mayer Brown Practices”). The Mayer Brown Practices are:
Mayer Brown LLP and Mayer Brown Europe – Brussels LLP, both limited
liability partnerships established in Illinois USA; Mayer Brown
International LLP, a limited liability partnership incorporated in
England and Wales (authorized and regulated by the Solicitors
Regulation Authority and registered in England and Wales number OC
303359); Mayer Brown, a SELAS established in France; Mayer Brown
JSM, a Hong Kong partnership and its associated entities in Asia;
and Tauil & Chequer Advogados, a Brazilian law partnership with
which Mayer Brown is associated. “Mayer Brown” and the
Mayer Brown logo are the trademarks of the Mayer Brown Practices in
their respective jurisdictions.
© Copyright 2020. The Mayer Brown Practices. All rights
Mayer Brown article provides information and comments on legal
issues and developments of interest. The foregoing is not a
comprehensive treatment of the subject matter covered and is not
intended to provide legal advice. Readers should seek specific
legal advice before taking any action with respect to the matters
POPULAR ARTICLES ON: Coronavirus (COVID-19) from United States